Dr.'s Choice all IPG, Omnicom

The Association of Medical Media (AMM) named its Doctors' Choice award winners, and Interpublic Group and Omnicom agencies dominated.

IPG's Draftfcb Healthcare and sibling Area 23 amassed three awards for work on behalf of King, GSK and Centocor. RCW Group notched two more, including the top-scoring ad—for Amgen's Nplate.

Ads by Omnicom's Cline Davis & Mann led two categories—OB/GYN and pulmonary—while Alcon and Genentech work by Omnicom's CAHG and AgencyRx got three more trophies.

An Abelson Taylor ad for Eli Lilly's Forteo Injection notched two awards, among three total for the indie shop.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.